Thomas John Dietz Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas John Dietz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas John Dietz. Thomas John Dietz is Director in Paratek Pharmaceuticals, Inc. ($PRTK) and Director in Eiger BioPharmaceuticals, Inc. ($EIGR) and Director in LEAP THERAPEUTICS, INC. ($LPTX).
Latest Insider Trading Transactions of Thomas John Dietz
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, EIGR, LPTX, PRTK
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 12 2021 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 8.50 | 1,000 | 8,500 | 37,500 | 36.5 K to 37.5 K (+2.74 %) |
Apr 12 2021 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 8.48 | 1,500 | 12,720 | 36,500 | 35 K to 36.5 K (+4.29 %) |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Option Exercise | A | 9.99 | 20,000 | 199,800 | 20,000 | |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Grant | A | 0.00 | 5,000 | 0 | 35,000 | 30 K to 35 K (+16.67 %) |
Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | A | 7.61 | 7,000 | 53,270 | 7,000 | |
Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Grant | A | 0.00 | 9,000 | 0 | 30,000 | 21 K to 30 K (+42.86 %) |
Jan 06 2021 | LPTX | LEAP THERAPEUTICS, ... | Dietz Thomas John | Director | Option Exercise | A | 2.18 | 37,300 | 81,314 | 37,300 | |
Aug 12 2020 | LPTX | LEAP THERAPEUTICS, ... | Dietz Thomas John | Director | Option Exercise | A | 1.97 | 12,500 | 24,625 | 12,500 | |
Apr 13 2020 | LPTX | LEAP THERAPEUTICS, ... | Dietz Thomas John | Director | Option Exercise | A | 1.69 | 12,500 | 21,125 | 12,500 | |
Mar 17 2020 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 4.95 | 1,000 | 4,950 | 30,000 | 29 K to 30 K (+3.45 %) |
Mar 13 2020 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Option Exercise | A | 5.60 | 20,000 | 112,000 | 20,000 | |
Mar 13 2020 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Grant | A | 0.00 | 5,000 | 0 | 29,000 | 24 K to 29 K (+20.83 %) |
Mar 04 2020 | LPTX | LEAP THERAPEUTICS, ... | Dietz Thomas John | Director | Option Exercise | A | 2.94 | 25,000 | 73,500 | 25,000 | |
Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | A | 3.51 | 7,000 | 24,570 | 7,000 | |
Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Grant | A | 0.00 | 9,000 | 0 | 21,000 | 12 K to 21 K (+75.00 %) |
Jan 13 2020 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 13.94 | 4,000 | 55,760 | 24,000 | 20 K to 24 K (+20.00 %) |
Jun 12 2019 | LPTX | LEAP THERAPEUTICS, ... | Dietz Thomas John | Director | Option Exercise | A | 1.39 | 15,000 | 20,850 | 15,000 | |
Apr 23 2019 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 11.10 | 5,000 | 55,495 | 20,000 | 15 K to 20 K (+33.33 %) |
Apr 22 2019 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 11.05 | 5,000 | 55,250 | 15,000 | 10 K to 15 K (+50.00 %) |
Apr 22 2019 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 11.05 | 5,000 | 55,250 | 15,000 | 10 K to 15 K (+50.00 %) |
Mar 25 2019 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Option Exercise | A | 13.41 | 20,000 | 268,200 | 20,000 | |
Mar 25 2019 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Option Exercise | A | 13.41 | 20,000 | 268,200 | 20,000 | |
Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | A | 7.23 | 5,000 | 36,150 | 5,000 | |
Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Grant | A | 0.00 | 7,500 | 0 | 12,000 | 4.5 K to 12 K (+166.67 %) |
Feb 20 2019 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Sell | S | 7.14 | 3,000 | 21,420 | 4,500 | 7.5 K to 4.5 K (-40.00 %) |
Jan 03 2019 | LPTX | LEAP THERAPEUTICS, ... | Dietz Thomas John | Director | Option Exercise | A | 2.00 | 9,375 | 18,750 | 9,375 | |
Dec 26 2018 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Sell | S | 5.01 | 9,330 | 46,743 | 7,500 | 16.8 K to 7.5 K (-55.44 %) |
Dec 20 2018 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 9.98 | 5,000 | 49,900 | 10,000 | 5 K to 10 K (+100.00 %) |
Dec 10 2018 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 11.26 | 5,000 | 56,300 | 5,000 | 0 to 5 K |
Apr 20 2018 | LPTX | LEAP THERAPEUTICS, ... | Dietz Thomas John | Director | Option Exercise | A | 7.66 | 11,250 | 86,175 | 11,250 | |
Mar 16 2018 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Option Exercise | A | 9.50 | 10,000 | 95,000 | 10,000 | |
Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | A | 14.15 | 5,000 | 70,750 | 5,000 | |
Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Grant | A | 0.00 | 7,500 | 0 | 16,830 | 9.3 K to 16.8 K (+80.39 %) |
Feb 07 2018 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Sell | S | 14.22 | 2,100 | 29,862 | 9,330 | 11.4 K to 9.3 K (-18.37 %) |
Apr 13 2017 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Option Exercise | A | 8.50 | 10,000 | 85,000 | 10,000 | |
Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | A | 15.10 | 6,000 | 90,600 | 6,000 | |
Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Grant | A | 0.00 | 6,000 | 0 | 11,430 | 5.4 K to 11.4 K (+110.50 %) |
Jan 23 2017 | LPTX | LEAP THERAPEUTICS, ... | Dietz Thomas John | Director | Option Exercise | A | 9.90 | 15,000 | 148,500 | 15,000 | |
Jan 23 2017 | LPTX | LEAP THERAPEUTICS, ... | Dietz Thomas John | Director | Option Exercise | A | 9.90 | 11,000 | 108,900 | 11,000 | |
Apr 01 2016 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Option Exercise | A | 15.75 | 23,000 | 362,250 | 23,000 | |
Apr 01 2016 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Option Exercise | A | 15.75 | 25,000 | 393,750 | 25,000 | |
Feb 08 2016 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | A | 14.05 | 12,000 | 168,600 | 12,000 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | D | 56.88 | 1,666 | 94,762 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | D | 41.16 | 2,083 | 85,736 | 0 | |
Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Grant | A | 0.00 | 5,430 | 0 | 5,430 | 0 to 5.4 K |
Apr 11 2013 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | A | 4.76 | 25,000 | 119,000 | 25,000 |
Page: 1